Skip to main content

Athersys talking to 'new potential partners' for its stem cell technology

For months, Athersys has been restructuring its operations and trying to raise cash to complete the testing and commercialization of MultiStem.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.